Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 53,737 | 0 | -6,651 | 3,208 | 33,971 |
| Gross Profit | 53,737 | N/A | -6,651 | 3,208 | 33,971 |
| Operating Expenses | 36,835 | 66,102 | 41,604 | 136,489 | 129,920 |
| Operating Income | 16,902 | -66,102 | -48,255 | -133,281 | -95,949 |
| Other Income | 12,919 | 18,390 | -5,170 | 128,991 | 185 |
| Pre-tax Income | 29,821 | -47,712 | -53,425 | -4,290 | -95,764 |
| Income Tax | N/A | 21 | 318 | 715 | 0 |
| Net Income Continuous | 29,821 | -47,733 | -53,743 | -5,005 | -95,764 |
| Net Income | $29,821 | $-47,733 | $-53,743 | $-5,005 | $-95,764 |
| EPS Basic Total Ops | 2.42 | -5.12 | -153.96 | -1.62 | -31.12 |
| EPS Basic Continuous Ops | 2.42 | -5.12 | -153.96 | -1.57 | -31.16 |
| EPS Diluted Total Ops | 2.42 | -6.58 | -153.96 | -1.62 | -31.12 |
| EPS Diluted Continuous Ops | 2.42 | -4.94 | -153.96 | -1.57 | -31.16 |
| EPS Diluted Before Non-Recurring Items | N/A | -6.58 | -32.73 | -1.62 | -31.12 |
| EBITDA(a) | $17,473 | $-65,642 | $-47,669 | $-133,935 | $-86,702 |